Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis. - Wikidata - wikimedia - TriplyDB

Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis.

Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis.

http://www.wikidata.org/entity/Q38092435

about

Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward Comparison of neoadjuvant versus a surgery first approach for gastric and esophagogastric cancer.Dose-dependent changes in renal (1)H-/(23)Na MRI after adjuvant radiochemotherapy for gastric cancer.Adjuvant Chemotherapy with Docetaxel, Cisplatin, and Continuous-Infusion 5-Fluorouracil for Gastric Cancer: A Phase II Study.Adjuvant therapy for gastric cancer: current and future directions.Proton therapy in adjuvant treatment of gastric cancer: planning comparison with advanced x-ray therapy and feasibility report.Postoperative chemoradiotherapy vs. preoperative chemoradiotherapy for locally advanced (operable) gastric cancer: clarifying the role and technique of radiotherapy.Evaluation of internal target volume in patients undergoing image-guided intensity modulated adjuvant radiation for gastric cancers Postoperative chemo-radiotherapy versus chemotherapy for resected gastric cancer: a systematic review and meta-analysis.Adjuvant and neoadjuvant options in resectable gastric cancer: is there an optimal treatment approach?Optimal management of resectable gastric adenocarcinoma.Perioperative chemotherapy versus postoperative chemoradiotherapy in patients with resectable gastric/gastroesophageal junction adenocarcinomas: A survival analysis of 5058 patients.Progress in the treatment of advanced gastric cancer.Prognostic effect of adjuvant chemoradiotherapy for patients with gastric cancer: an updated evidence of randomized controlled trials.Outcomes of radiation therapy for resectable M0 gastric cancer.Progress of preoperative and postoperative radiotherapy in gastric cancer

P2860

Q26738505-0B247A48-5EF9-4AEF-8F6C-CB2A42D8E70F Q26858776-8ECB7BE2-323C-4C1D-ABAD-984F6BCD04EF Q30248541-A79E37F0-C299-40BC-AD30-081C35C22CFE Q30872867-9554FA4A-17A1-454B-B54D-AA2D3F4ECB4E Q33912309-45DFD09F-C7D7-4951-89ED-892A15A63987 Q34326579-E48E49B6-1A15-4EDC-8E9F-8187976E5DDE Q34418908-1BD8EC01-54EB-460A-A985-B4DCA37A9553 Q34962091-C7494447-A4C7-4566-9DFF-5597CFD35DC1 Q37504866-9EB6A220-952D-4787-8FC9-D96BBB7576B8 Q38226324-9D7D27D5-F766-496E-8E6D-1527A2C16BE8 Q38364619-EB8724EF-AE57-465D-80FA-C497C44505C0 Q38545533-A8E68F82-8188-414C-8713-CFB6951B2ABE Q38848598-8DC42E5E-4B6B-412F-997F-CD4E7E913E4B Q39410760-A5458AC5-8042-4294-9293-F7E8AEBB62CC Q47157584-68029658-36B7-4337-BB86-FF930826CD65 Q49164896-C810D024-F4CB-454D-ACE4-EB3360CC133A Q58743551-02B87DE1-9217-4224-BC74-FCA32EC7EC28

P2860

Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis.

http://www.wikidata.org/entity/Q38092435

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis.

@en

type

label

Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis.

@en

prefLabel

Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis.

@en

P1433

Q38092435-1A237E5F-FAFC-488F-BA36-B0EA01BCBEC6

P1476

Q38092435-7D9403D5-378D-418C-9F1C-0E7F3D2B3750

P2093

Q38092435-0E3D26D5-6604-42B1-9E1F-7A729C7B1647

Q38092435-2E16C304-4192-4F16-B7E5-A9F8349D7EA1

Q38092435-42CA6694-4E1B-45D1-9609-E56BA5A63F1F

Q38092435-5E776AD1-5F0C-475C-8327-98B4CDA09DEE

Q38092435-72589077-369C-49A8-A2F2-F4F30EE68E2F

Q38092435-ACC231C5-67EC-4DD7-98D0-21EA4920427D

Q38092435-BC04780C-11FC-413F-9254-4D43C7228DC2

P2860

Q38092435-09DF9AC2-8FEB-4B9D-8167-842B4E668972

Q38092435-0FFE3FA5-7C76-4A1D-A613-81E7FFA51A9D

Q38092435-19D83E1B-0454-4F96-B9FF-33109E93D64D

Q38092435-1EED8510-6AF0-4984-BCD9-85FE0AF81EA5

Q38092435-2703E3E6-6997-4152-B6F4-86E40E832600

Q38092435-28394BEB-BE98-4719-A383-6B0ACDF277D6

Q38092435-49D91A30-929F-4E02-9C42-B6DE3BD8C245

Q38092435-4C5BF3A0-8983-4A2A-ADA6-046FCBFD8A6C

Q38092435-521D741E-CE54-4E40-9679-79DD6CCACF80

Q38092435-556E035D-13B7-4E7B-B57C-2B7C9BC58196

P304

Q38092435-D63D8033-A928-4A85-8FAE-AF191E53A92B

P31

Q38092435-39F5D50D-5E1F-43BC-A1E9-4549C0B5759D

Q38092435-57b569c0-db7b-4cfc-847d-f4172bcc699f

P356

Q38092435-15018D7F-64EE-4942-A810-C14CFA3DCBF0

P407

Q38092435-C0D4E731-03CF-451F-954A-CD44FA2BAF7A

P433

Q38092435-CE1B8CCB-5EC4-470E-93D6-DFD0F1990C1E

P478

Q38092435-63C66A4F-C279-4A8E-A9D3-60A3659A0F66

P50

Q38092435-D2BF837F-3490-47B0-A653-BC781B92481F

P577

Q38092435-C76EE649-77D9-4BAE-A936-6D911CD88C24

P698

Q38092435-3C43CF48-4D51-4100-8E8B-C0A47ECA185A

P921

Q38092435-B6B59A0C-ED67-4EAA-B872-75EEFDB407D6

P932

Q38092435-1DEF00C2-67D9-4AD1-94F9-373FA4F16062

P356

J.IJROBP.2013.02.008

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis.

@en

P2093

Andreas Kaubisch

http://www.w3.org/2001/XMLSchema#string

Chandan Guha

http://www.w3.org/2001/XMLSchema#string

Madhur K Garg

http://www.w3.org/2001/XMLSchema#string

Nitin Ohri

http://www.w3.org/2001/XMLSchema#string

Santiago Aparo

http://www.w3.org/2001/XMLSchema#string

Shalom Kalnicki

http://www.w3.org/2001/XMLSchema#string

Timothy J Kennedy

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data.

Meta-analysis when only the median survival times are known: a comparison with individual patient data results.

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS).

Global patterns of cancer incidence and mortality rates and trends.

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

P304

330-335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2013.02.008

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23523184

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

3817859

http://www.w3.org/2001/XMLSchema#string